Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York 14214, USA.
J Pharm Sci. 2013 Sep;102(9):2930-40. doi: 10.1002/jps.23590. Epub 2013 May 16.
Building upon many classical foundations of pharmacology, a diverse array of mechanistic pharmacokinetic-pharmacodynamic (PK/PD) models have emerged based on mechanisms of drug action and primary rate-limiting or turnover processes in physiology. An array of basic models can be extended to handle various complexities including tolerance and can readily be employed as building blocks in assembling enhanced PK/PD or small systems models. Our corticosteroid models demonstrate these concepts as well as elements of horizontal and vertical integration of molecular to whole-body processes. The potential advantages and challenges in moving PK/PD toward systems models are described.
在药理学的许多经典基础上,已经出现了基于药物作用机制和生理学中主要限速或周转过程的多样化的机制药代动力学-药效动力学(PK/PD)模型。一系列基本模型可以扩展以处理各种复杂性,包括耐受性,并且可以很容易地用作组装增强的 PK/PD 或小系统模型的构建块。我们的皮质类固醇模型展示了这些概念,以及分子到全身过程的水平和垂直整合的要素。还描述了将 PK/PD 推向系统模型的潜在优势和挑战。